NEW DELHI: India is likely to have a Covid-19 vaccine in the new year, India’s general drug controller VG Somani hinted on Thursday. Speaking at a webinar, Somani said most importantly, industry and research organizations have stood the test of time. He said that the vaccine candidates got the funding …
Read More »
NEW DELHI: The UK on Wednesday became the first country in the world to approve the coronavirus vaccine developed by the University of Oxford-AstraZeneca. India is likely to follow suit soon. The Serum Institute of India (SII), the world’s largest producer of vaccines, has already produced almost 50 million doses …
Read More »
AstraZeneca Plc will soon publish data showing that the effectiveness of its covid-19 vaccine increases up to 95% if the two injections are separated by approximately 2-3 months, said Adar Poonawalla, executive director of the Serum Institute of India (SII), partner. manufacturing company British. “You will be getting good news …
Read More »
NEW DELHI: India is likely to see the Oxford-AstraZeneca vaccine approved for emergency use in the coming days, as updated data presented by the Serum Institute of India (SII) appears “satisfactory,” top government sources said. Once the data assessment is complete, the regulator may not wait for the vaccine to …
Read More »
The two-day activity is scheduled for December 28 and 29. A trial for the administration of the COVID-19 vaccine has been planned in four states of the country next week, according to a statement issued by the Union government on Friday. The four states include Andhra Pradesh, Assam, Gujarat, and …
Read More »
Covaxin can generate antibodies that can persist for 6 to 12 months, Bharat Biotech said. (Archive) Hyderabad: Covaxin, a COVID-19 vaccine developed by Bharat Biotech, showed long-term memory responses of antibodies and T (immune) cells three months after injection in phase 1 volunteers and tolerable safety results in phase 2 …
Read More »
Hyderabad-based Bharat Biotech has applied for the Emergency Use Authorization of its COVID-19 COVAXIN vaccine again with the Comptroller General of Drugs of India (DCGI), sources told News18 on Wednesday. COVAXIN, an inactivated candidate vaccine, is currently in phase III human clinical trials with 26,000 volunteers at 25 centers in …
Read More »
HYDERABAD: India’s first indigenous Covid-19 vaccine, Covaxin, has shown long-term antibody and T-cell memory responses three months after vaccination in phase I volunteers Covaxin can generate antibodies that can persist for 6 to 12 months, Bharat Biotech said in a research article. According to the document uploaded to ‘medRxiv’, a …
Read More »
According to the company, the vaccine is developed and manufactured at Bharat Biotech’s BSL-3 biocontainment facility. “This is an unprecedented vaccine trial to be conducted in India, and we are overwhelmed by the steady increase in participation. We sincerely thank all 13,000 volunteers across the country for their support in …
Read More »
MUMBAI: India will produce around 300 million doses from Russia Sputnik V vaccines against coronavirus next year, Russian officer it was quoted as saying, almost three times the number previously known, as deals have been signed with more manufacturers. Russia is already testing the first Sputnik V samples that were …
Read More »